Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:40 AM
Ignite Modification Date:
2025-12-25 @ 12:40 AM
NCT ID:
NCT00571467
Eligibility Criteria:
Inclusion Criteria:
* Diagnosis of chronic ITP \> 4 months
* Mean platelet count \<50 x 10\^9/L for patients not receiving corticosteroids; or mean platelet count \>=50 x 10\^9/L for patients receiving stable dose of corticosteroids
Exclusion Criteria:
* Splenectomy within 45 days of screening
* Rituximab within 6 months prior to screening
* Cyclophosphamide, vincristine, or any other non-monoclonal antibody treatment for ITP within 3 months prior to screening
* IVIG, WinRho or other anti-RhD within 30 days prior to screening
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00571467
Study Brief:
Protocol Section:
NCT00571467